SELUTION DeNovo:
Sirolimus-Eluting DCB vs. DES in De Novo Coronary Lesions

Christian M. Spaulding

SELUTION4ISR:
Sirolimus-Eluting DCB vs. DES or Balloon Angioplasty for In-Stent Restenosis

Donald Cutlip

Short-CUT:
Intravascular Lithotripsy vs. Cutting Balloon Angioplasty in Calcified CAD

Suzanne J. Baron

VICTORY:
Intravascular Lithotripsy vs. Super-High-Pressure PTCA in Calcified and Refractory Coronary Lesions

Matthias Bossard

PREVUE-Valve:
A Site-Less Study to Determine the Prevalence of Valvular Heart Disease in Older Americans

David J. Cohen

PARTNER 3:
7-Year Clinical and Echocardiographic Outcomes of TAVR vs. SAVR

Michael J. Mack

SUMMIT:
1-year Outcomes of Tendyne TMVR for Treatment of Severe Mitral Annular Calcification

Paul Sorajja

ENCIRCLE:
1-Year Outcomes of TMVR With the SAPIEN M3 System for Patients Unsuitable for Surgery

David Daniels

PROCTOR:
Native Vessel vs. SVG PCI in Patients With Prior CABG

Ruben de Winter

STRIVE:
Low-Dose r-tPA vs. Placebo in STEMI With Large Thrombus Burden

Shamir R. Mehta

iMODERN:
iFR- vs. Cardiac MRI-Guided Revascularization of Non-Culprit Lesions in STEMI

Robin Nijveldt

PROMISE:
Personalized vs. Conventional Management of Patients with MINOCA

Rocco Antonio Montone

TUXEDO-2:
Supraflex Cruz vs. Xience DES in Patients with Diabetes and Multivessel CAD

Upendra Kaul

STORM-PE:
Mechanical Thrombectomy vs. Anticoagulation Alone for Intermediate-to-High Risk PE

Robert A. Lookstein

LIFE-BTK 3 Year Outcomes:
Drug-Eluting Resorbable Scaffold vs. PTA for Infrapopliteal Lesions

Sahil A. Parikh

ANDES:
OAC vs. DAPT for Prevention of Device Thrombosis After LAAC

Josep Rodés-Cabau

TRILUMINATE:
Novel Insights from the Pivotal Trial and Registries

Jonathan G. Schwartz

EVOQUE:
Early Commercial Experience From the US TVT Registry

Raj Makkar

INFINITY-SWEDEHEART:
2-Year Outcomes of PCI with Bioadaptor Implant vs. Conventional DES

David Erlinge

OCVC-BIF:
DCB vs. Conventional PTCA for Treatment of Bifurcation Lesion Side-Branches

Takayuki Ishihara

IRONMAN II:
2-Year Outcomes of Sirolimus-Eluting Bioresorbable Scaffolds vs. DES

Lei Song

REC-CAGEFREE 1:
3-Year Outcomes of DCB vs. DES for De Novo Coronary Lesions

Chao Gao

NOBLE:
10-Year Mortality With DES-PCI vs. CABG for LM Disease

Evald H. Christiansen

iCABG:
iFR vs. Angiography Guided CABG

Rasa Ordiene

MULTIVESSEL TALENT:
Supraflex Cruz vs. SYNERGY DES in Multivessel CAD

Patrick W. Serruys

NyokASSIST PVAD vs. IABP for Patients Undergoing High-Risk PCI

Rui Wang

Real-World Performance of AI-Enabled ECG Interpretation in Suspected STEMI

Timothy D. Henry

INVEST-CTO:
Single Arm Study of a Planned Investment Procedure in High-Risk CTO PCI

Anja Oksnes